420 related articles for article (PubMed ID: 18387898)
21. Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Bouza E; Burillo A; Muñoz P
Med Clin North Am; 2006 Nov; 90(6):1141-63. PubMed ID: 17116441
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
23. Emergence of Clostridium difficile-associated disease in North America and Europe.
Kuijper EJ; Coignard B; Tüll P; ; ;
Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
25. The potential for emerging therapeutic options for Clostridium difficile infection.
Mathur H; Rea MC; Cotter PD; Ross RP; Hill C
Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777
[TBL] [Abstract][Full Text] [Related]
26. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
[TBL] [Abstract][Full Text] [Related]
27. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
29. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Clostridium difficile infection.
Gerding DN; Muto CA; Owens RC
Clin Infect Dis; 2008 Jan; 46 Suppl 1():S32-42. PubMed ID: 18177219
[TBL] [Abstract][Full Text] [Related]
31. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
[TBL] [Abstract][Full Text] [Related]
34. Emerging therapies in the treatment of Clostridium difficile-associated disease.
Jodlowski TZ; Oehler R; Kam LW; Melnychuk I
Ann Pharmacother; 2006 Dec; 40(12):2164-9. PubMed ID: 17119105
[TBL] [Abstract][Full Text] [Related]
35. The changing face of Clostridium difficile: what treatment options remain?
Shen EP; Surawicz CM
Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
[TBL] [Abstract][Full Text] [Related]
36. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea.
Parkes GC; Sanderson JD; Whelan K
Lancet Infect Dis; 2009 Apr; 9(4):237-44. PubMed ID: 19324296
[TBL] [Abstract][Full Text] [Related]
37. [Clostridium-difficile-associated infections].
Eckert C; Barbut F
Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046
[TBL] [Abstract][Full Text] [Related]
38. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile: recent epidemiologic findings and advances in therapy.
McMaster-Baxter NL; Musher DM
Pharmacotherapy; 2007 Jul; 27(7):1029-39. PubMed ID: 17594209
[TBL] [Abstract][Full Text] [Related]
40. The management of Clostridium difficile-associated diarrhoea in a community hospital.
Tomkins K; Raynor J; Rothwell L; DeSilva J; Wilson C
West Indian Med J; 2011 Jan; 60(1):57-60. PubMed ID: 21809713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
